Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists-Daridorexant, Lemborexant, and Suvorexant-Part 2. Principal Drug Metabolizing Enzyme, Drug-Drug Interactions, and Effects of Liver and Renal Impairment on Metabolism.
J Psychiatr Pract
; 29(1): 38-41, 2023 01 01.
Article
in En
| MEDLINE
| ID: mdl-36649550
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Orexin Receptor Antagonists
/
Sleep Initiation and Maintenance Disorders
Limits:
Humans
Language:
En
Journal:
J Psychiatr Pract
Journal subject:
PSIQUIATRIA
Year:
2023
Document type:
Article